Newsfeeds Archive - Page 4 of 4

2 minute read

Werewolf Therapeutics To Present Preclinical Data At Society For Immunotherapy Of Cancer Annual Meeting And Participate In Upcoming Investor Conferences

November 7, 5:59 PM

Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to

HOWL

9 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

November 7, 1:47 PM

On Monday, 160 companies hit new 52-week lows.

$APE

6 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

October 27, 12:43 PM

On Thursday, 111 stocks hit new 52-week lows.

ADIL

5 minute read

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday

By Lisa Levin

September 6, 2:55 AM

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

$APE

6 minute read

Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday

By Lisa Levin

September 2, 5:29 AM

Gainers

AGIO

3 minute read

Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

September 1, 6:36 PM

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002,…

AXSM

1 minute read

Werewolf Shares Climb As Initial-Stage Solid Tumors Study Kicks-off

By Ragothaman Srinivasan

September 1, 10:14 AM

Werewolf Therapeutics (NASDAQ: HOWL) has initiated patient dosing in a Phase 1/1b clinical trial evaluating WTX-124, its lead INDUKINET molecule targeting IL-2 for the treatment of solid tumors.

HOWL

1 minute read

News

Overview Of Value Stocks In The Healthcare Sector

By Benzinga Insights

August 29, 10:49 AM

What are Value Stocks?

ASRT